Related Experiment Video
Updated: Aug 4, 2025
Basics of Multivariate Analysis in Neuroimaging Data
Published on: July 24, 2010
Classification of Alzheimer's disease based on hippocampal multivariate morphometry statistics
Weimin Zheng1, Honghong Liu2, Zhigang Li2
1Department of Radiology, Aerospace Center Hospital, Beijing, China.
Background:
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline, and mild cognitive impairment (MCI) is associated with a high risk of developing AD. Hippocampal morphometry analysis is believed to be the most robust magnetic resonance imaging (MRI) markers for AD and MCI. Multivariate morphometry statistics (MMS), a quantitative method of surface deformations analysis, is confirmed to have strong statistical power for evaluating hippocampus.
Aims:
We aimed to test whether surface deformation features in hippocampus can be employed for early classification of AD, MCI, and healthy controls (HC).
Methods:
We first explored the differences in hippocampus surface deformation among these three groups by using MMS analysis. Additionally, the hippocampal MMS features of selective patches and support vector machine (SVM) were used for the binary classification and triple classification.
Results:
By the results, we identified significant hippocampal deformation among the three groups, especially in hippocampal CA1. In addition, the binary classification of AD/HC, MCI/HC, AD/MCI showed good performances, and area under curve (AUC) of triple-classification model achieved 0.85. Finally, positive correlations were found between the hippocampus MMS features and cognitive performances.
Conclusions:
The study revealed significant hippocampal deformation among AD, MCI, and HC. Additionally, we confirmed that hippocampal MMS can be used as a sensitive imaging biomarker for the early diagnosis of AD at the individual level.
Insights
Multivariate morphometry statistics reveal significant hippocampal deformation in Alzheimer's disease (AD) and mild cognitive impairment (MCI). This imaging biomarker aids in early AD diagnosis and correlates with cognitive performance.
Area of Science:
- Neuroimaging
- Biomarker Discovery
- Neurology
Background:
- Alzheimer's disease (AD) and mild cognitive impairment (MCI) involve progressive cognitive decline.
- Hippocampal morphometry using magnetic resonance imaging (MRI) are key markers for AD and MCI.
- Multivariate morphometry statistics (MMS) quantifies surface deformations for robust hippocampus evaluation.
Purpose of the Study:
- To assess if hippocampal surface deformation features can classify AD, MCI, and healthy controls (HC).
- To investigate MMS as a potential imaging biomarker for early AD detection.
Main Methods:
- Explored differences in hippocampus surface deformation among AD, MCI, and HC groups using MMS analysis.
- Utilized hippocampal MMS features with support vector machine (SVM) for binary and triple classification.
- Analyzed selective patches for detailed feature extraction.
Main Results:
- Identified significant hippocampal deformation differences across the three groups, particularly in the hippocampal CA1 region.
- Achieved good performance in binary classifications (AD/HC, MCI/HC, AD/MCI).
- The triple-classification model yielded an area under the curve (AUC) of 0.85, demonstrating strong diagnostic potential.
Conclusions:
- Significant hippocampal deformation is evident in individuals with AD, MCI, and HC.
- Hippocampal MMS serves as a sensitive imaging biomarker for the early, individual-level diagnosis of AD.
- The findings support the use of MMS in clinical settings for neurodegenerative disease assessment.
